Home › Funds › Knott David M Jr › XERS
Knott David M Jr position in XERS
XERIS BIOPHARMA HOLDINGS INC · Health Care
Knott David M Jr reported holding 1,002,900 shares of XERS (XERIS BIOPHARMA HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$9.6M, representing 5.24% of its reported portfolio and ranking #4 among its reported holdings. Knott David M Jr has disclosed XERS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Knott David M Jr's XERS position evolved
Knott David M Jr first disclosed a stake in XERS in Q4 2023 at 387,910 shares (US$912K). The position peaked in Q3 2026 at 1,002,900 shares, worth US$9.6M. Across 12 filings, Knott David M Jr increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,002,900 shares valued at US$9.6M — a reduction of -57,100 shares quarter over quarter.. Notable position changes include a 55% increase in Q1 2024 (shares rose 2% over the following quarter), a 37% increase in Q2 2024 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 387.91K | $912.00K | New |
| Q1 2024 | 600.00K | $1.33M | Add |
| Q2 2024 | 820.00K | $1.84M | Add |
| Q3 2024 | 1.00M | $2.85M | Add |
| Q4 2024 | 1.00M | $3.39M | Hold |
| Q1 2025 | 1.11M | $6.09M | Add |
| Q2 2025 | 1.06M | $4.95M | Reduce |
| Q3 2025 | 1.01M | $8.26M | Reduce |
| Q4 2025 | 970.00K | $7.61M | Reduce |
| Q1 2026 | 1.06M | $6.15M | Add |
| Q2 2026 | 1.06M | $8.40M | Hold |
| Q3 2026 | 1.00M | $9.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XERS and 13F data
XERS (XERIS BIOPHARMA HOLDINGS INC) is a Health Care company. 52 other funds we track also report a position in XERS — the largest reported positions include CAPSTONE INVESTMENT ADVISORS, LLC (US$62.6M), Polar Asset Management Partners Inc. (US$28.8M), Rosalind Advisors, Inc. (US$23.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XERS
- CAPSTONE INVESTMENT ADVISORS, LLC 23.07M sh · $62.64M · Q2 2026
- Polar Asset Management Partners Inc. 10.50M sh · $28.80M · Q2 2026
- Rosalind Advisors, Inc. 2.91M sh · $23.04M · Q2 2026
- Parkman Healthcare Partners LLC 1.81M sh · $14.32M · Q2 2026
- Vilga Financial Planning LLC 1.06M sh · $10.13M · Q3 2026
- Ishara Investments LP 1.23M sh · $9.74M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 693.26K sh · $6.63M · Q3 2026
More on Knott David M Jr
FAQ
How long has Knott David M Jr held XERS?
Knott David M Jr has disclosed XERS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Knott David M Jr's current position in XERS?
As of Q3 2026, Knott David M Jr holds 1.00M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), valued at $9.59M, representing 5.24% of its reported portfolio and ranking #4.
Has Knott David M Jr been buying or selling XERS?
In the latest 13F filing (Q3 2026), Knott David M Jr reduced its position in XERS. The position peaked in Q3 2026 at 1.00M shares.
Which other funds hold XERS?
Other major institutional holders of XERS include CAPSTONE INVESTMENT ADVISORS, LLC, Polar Asset Management Partners Inc., Rosalind Advisors, Inc., among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.